Gyre Therapeutics, Inc.
GYRE • NASDAQ
Gyre Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ping Zhang, with a market cap of $661.1M.
Market Cap$661.1M
Employees391.0
CEOPing Zhang
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
GYR
Gyre Therapeutics, Inc. FAQ
Common questions about Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $32.5M.
Gyre Therapeutics, Inc. has approximately 391 employees.